<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32046135</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Implication of 5-HT in the Dysregulation of Chloride Homeostasis in Prenatal Spinal Motoneurons from the G93A Mouse Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1107</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21031107</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron degeneration and muscle paralysis. The early presymptomatic onset of abnormal processes is indicative of cumulative defects that ultimately lead to a late manifestation of clinical symptoms. It remains of paramount importance to identify the primary defects that underlie this condition and to determine how these deficits lead to a cycle of deterioration. We recently demonstrated that prenatal E17.5 lumbar spinal motoneurons (MNs) from SOD1<sup>G93A</sup> mice exhibit a KCC2-related alteration in chloride homeostasis, i.e., the E<sub>GABAAR</sub> is more depolarized than in WT littermates. Here, using immunohistochemistry, we found that the SOD1<sup>G93A</sup> lumbar spinal cord is less enriched with 5-HT descending fibres than the WT lumbar spinal cord. High-performance liquid chromatography confirmed the lower level of the monoamine 5-HT in the SOD1<sup>G93A</sup> spinal cord compared to the WT spinal cord. Using ex vivo perforated patch-clamp recordings of lumbar MNs coupled with pharmacology, we demonstrated that 5-HT strongly hyperpolarizes the E<sub>GABAAR</sub> by interacting with KCC2. Therefore, the deregulation of the interplay between 5-HT and KCC2 may explain the alteration in chloride homeostasis detected in prenatal SOD1<sup>G93A</sup> MNs. In conclusion, 5-HT and KCC2 are two likely key factors in the presymptomatic phase of ALS, particular in familial ALS involving the SOD1<sup>G93A</sup> mutation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Elodie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Bordeaux, CNRS, INCIA, UMR 5287, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cazenave</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University of Bordeaux, CNRS, INCIA, UMR 5287, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allain</LastName><ForeName>Anne-Emilie</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>University of Bordeaux, CNRS, INCIA, UMR 5287, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cattaert</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-4471-0525</Identifier><AffiliationInfo><Affiliation>University of Bordeaux, CNRS, INCIA, UMR 5287, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Branchereau</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3972-8229</Identifier><AffiliationInfo><Affiliation>University of Bordeaux, CNRS, INCIA, UMR 5287, F-33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2013 - 2016</GrantID><Agency>Association pour la recherche sur la Scl&#xe9;rose Lat&#xe9;rale Amyotrophique et autres maladies du Motoneurone (ARSLA)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002712">Chlorides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D027981">Symporters</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C058648">potassium-chloride symporters</NameOfSubstance></Chemical><Chemical><RegistryNumber>333DO1RDJY</RegistryNumber><NameOfSubstance UI="D012701">Serotonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>56-12-2</RegistryNumber><NameOfSubstance UI="D005680">gamma-Aminobutyric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>TE7660XO1C</RegistryNumber><NameOfSubstance UI="D005998">Glycine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002712" MajorTopicYN="N">Chlorides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005998" MajorTopicYN="N">Glycine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012701" MajorTopicYN="N">Serotonin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D027981" MajorTopicYN="N">Symporters</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005680" MajorTopicYN="N">gamma-Aminobutyric Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5-HT</Keyword><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">GABA/glycine</Keyword><Keyword MajorTopicYN="N">SOD1G93A mouse</Keyword><Keyword MajorTopicYN="N">chloride homeostasis</Keyword><Keyword MajorTopicYN="N">development</Keyword><Keyword MajorTopicYN="N">motoneuron</Keyword><Keyword MajorTopicYN="N">perforated patch-clamp</Keyword><Keyword MajorTopicYN="N">spinal cord</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32046135</ArticleId><ArticleId IdType="pmc">PMC7039234</ArticleId><ArticleId IdType="doi">10.3390/ijms21031107</ArticleId><ArticleId IdType="pii">ijms21031107</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van Damme P., Robberecht W., Van Den Bosch L. Modelling amyotrophic lateral sclerosis: Progress and possibilities. Dis. Model. Mech. 2017;10:537&#x2013;549. doi: 10.1242/dmm.029058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029058</ArticleId><ArticleId IdType="pmc">PMC5451175</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti L., Ghilardi A., Rottoli E., De Maglie M., Prosperi L., Perego C., Baruscotti M., Bucchi A., Del Giacco L., Francolini M. INaP selective inhibition reverts precocious inter- and motorneurons hyperexcitability in the Sod1-G93R zebrafish ALS model. Sci. Rep. 2016;6:24515. doi: 10.1038/srep24515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24515</ArticleId><ArticleId IdType="pmc">PMC4832213</ArticleId><ArticleId IdType="pubmed">27079797</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin E., Cazenave W., Cattaert D., Branchereau P. Embryonic alteration of motoneuronal morphology induces hyperexcitability in the mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;54:116&#x2013;126. doi: 10.1016/j.nbd.2013.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.02.011</ArticleId><ArticleId IdType="pubmed">23466698</ArticleId></ArticleIdList></Reference><Reference><Citation>Koschnitzky J.E., Quinlan K.A., Lukas T.J., Kajtaz E., Kocevar E.J., Mayers W.F., Siddique T., Heckman C.J. Effect of fluoxetine on disease progression in a mouse model of ALS. J. Neurophysiol. 2014;111:2164&#x2013;2176. doi: 10.1152/jn.00425.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00425.2013</ArticleId><ArticleId IdType="pmc">PMC4097867</ArticleId><ArticleId IdType="pubmed">24598527</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubenstein J.L. Development of serotonergic neurons and their projections. Biol. Psychiatry. 1998;44:145&#x2013;150. doi: 10.1016/S0006-3223(98)00133-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3223(98)00133-4</ArticleId><ArticleId IdType="pubmed">9693386</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeiren Y., Janssens J., Van Dam D., De Deyn P.P. Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson&#x2019;s Disease: Similar Mechanisms, Dissimilar Outcomes. Front. Neurosci. 2018;12:185. doi: 10.3389/fnins.2018.00185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00185</ArticleId><ArticleId IdType="pmc">PMC5869258</ArticleId><ArticleId IdType="pubmed">29615862</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992;72:165&#x2013;229. doi: 10.1152/physrev.1992.72.1.165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1992.72.1.165</ArticleId><ArticleId IdType="pubmed">1731370</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlstr&#xf6;m A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 1964;62:1&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">14229500</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidov H.G., Molliver M.E. Immunohistochemical study of the development of serotonergic neurons in the rat CNS. Brain Res. Bull. 1982;9:559&#x2013;604. doi: 10.1016/0361-9230(82)90164-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0361-9230(82)90164-2</ArticleId><ArticleId IdType="pubmed">6756556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye W., Shimamura K., Rubenstein J.L., Hynes M.A., Rosenthal A. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell. 1998;93:755&#x2013;766. doi: 10.1016/S0092-8674(00)81437-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81437-3</ArticleId><ArticleId IdType="pubmed">9630220</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajaofetra N., Sandillon F., Geffard M., Privat A. Pre- and post-natal ontogeny of serotonergic projections to the rat spinal cord. J. Neurosci. Res. 1989;22:305&#x2013;321. doi: 10.1002/jnr.490220311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.490220311</ArticleId><ArticleId IdType="pubmed">2709447</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballion B., Branchereau P., Chapron J., Viala D. Ontogeny of descending serotonergic innervation and evidence for intraspinal 5-HT neurons in the mouse spinal cord. Brain Res. Dev. Brain Res. 2002;137:81&#x2013;88. doi: 10.1016/S0165-3806(02)00414-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-3806(02)00414-5</ArticleId><ArticleId IdType="pubmed">12128257</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace J.A., Lauder J.M. Development of the serotonergic system in the rat embryo: An immunocytochemical study. Brain Res. Bull. 1983;10:459&#x2013;479. doi: 10.1016/0361-9230(83)90144-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0361-9230(83)90144-2</ArticleId><ArticleId IdType="pubmed">6344960</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: News from mouse molecular genetics. Nat. Rev. 2003;4:1002&#x2013;1012. doi: 10.1038/nrn1256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1256</ArticleId><ArticleId IdType="pubmed">14618156</ArticleId></ArticleIdList></Reference><Reference><Citation>Branchereau P., Chapron J., Meyrand P. Descending 5-hydroxytryptamine raphe inputs repress the expression of serotonergic neurons and slow the maturation of inhibitory systems in mouse embryonic spinal cord. J. Neurosci. 2002;22:2598&#x2013;2606. doi: 10.1523/JNEUROSCI.22-07-02598.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-07-02598.2002</ArticleId><ArticleId IdType="pmc">PMC6758300</ArticleId><ArticleId IdType="pubmed">11923425</ArticleId></ArticleIdList></Reference><Reference><Citation>Allain A.E., Meyrand P., Branchereau P. Ontogenic changes of the spinal GABAergic cell population are controlled by the serotonin (5-HT) system: Implication of 5-HT1 receptor family. J. Neurosci. 2005;25:8714&#x2013;8724. doi: 10.1523/JNEUROSCI.2398-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2398-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725515</ArticleId><ArticleId IdType="pubmed">16177041</ArticleId></ArticleIdList></Reference><Reference><Citation>Delpy A., Allain A.E., Meyrand P., Branchereau P. NKCC1 cotransporter inactivation underlies embryonic development of chloride-mediated inhibition in mouse spinal motoneuron. J. Physiol. 2008;586:1059&#x2013;1075. doi: 10.1113/jphysiol.2007.146993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.146993</ArticleId><ArticleId IdType="pmc">PMC2375629</ArticleId><ArticleId IdType="pubmed">18096599</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell J.M. Sodium-potassium-chloride cotransport. Physiol. Rev. 2000;80:211&#x2013;276. doi: 10.1152/physrev.2000.80.1.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.2000.80.1.211</ArticleId><ArticleId IdType="pubmed">10617769</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera C., Voipio J., Payne J.A., Ruusuvuori E., Lahtinen H., Lamsa K., Pirvola U., Saarma M., Kaila K. The K+/Cl&#x2212; co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature. 1999;397:251&#x2013;255. doi: 10.1038/16697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/16697</ArticleId><ArticleId IdType="pubmed">9930699</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty M.J. Driven to decay: Excitability and synaptic abnormalities in amyotrophic lateral sclerosis. Brain Res. Bull. 2018;140:318&#x2013;333. doi: 10.1016/j.brainresbull.2018.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.05.023</ArticleId><ArticleId IdType="pubmed">29870780</ArticleId></ArticleIdList></Reference><Reference><Citation>Branchereau P., Martin E., Allain A.E., Cazenave W., Supiot L., Hodeib F., Laupenie A., Dalvi U., Zhu H., Cattaert D. Relaxation of synaptic inhibitory events as a compensatory mechanism in fetal SOD spinal motor networks. Elife. 2019:8. doi: 10.7554/eLife.51402.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.51402</ArticleId><ArticleId IdType="pmc">PMC6974356</ArticleId><ArticleId IdType="pubmed">31868588</ArticleId></ArticleIdList></Reference><Reference><Citation>Bos R., Sadlaoud K., Boulenguez P., Buttigieg D., Liabeuf S., Brocard C., Haase G., Bras H., Vinay L. Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2. Proc. Natl. Acad. Sci. USA. 2013;110:348&#x2013;353. doi: 10.1073/pnas.1213680110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1213680110</ArticleId><ArticleId IdType="pmc">PMC3538195</ArticleId><ArticleId IdType="pubmed">23248270</ArticleId></ArticleIdList></Reference><Reference><Citation>Brustein E., Drapeau P. Serotoninergic modulation of chloride homeostasis during maturation of the locomotor network in zebrafish. J. Neurosci. 2005;25:10607&#x2013;10616. doi: 10.1523/JNEUROSCI.2017-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2017-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725851</ArticleId><ArticleId IdType="pubmed">16291933</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulenguez P., Liabeuf S., Bos R., Bras H., Jean-Xavier C., Brocard C., Stil A., Darbon P., Cattaert D., Delpire E., et al. Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury. Nat. Med. 2010;16:302&#x2013;307. doi: 10.1038/nm.2107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2107</ArticleId><ArticleId IdType="pubmed">20190766</ArticleId></ArticleIdList></Reference><Reference><Citation>Oueghlani Z., Juvin L., Lambert F.M., Cardoit L., Courtand G., Masmejean F., Cazalets J.R., Barriere G. Serotonergic modulation of sacral dorsal root stimulation-induced locomotor output in newborn rat. Neuropharmacology. 2019 doi: 10.1016/j.neuropharm.2019.107815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2019.107815</ArticleId><ArticleId IdType="pubmed">31634501</ArticleId></ArticleIdList></Reference><Reference><Citation>Slawinska U., Miazga K., Jordan L.M. The role of serotonin in the control of locomotor movements and strategies for restoring locomotion after spinal cord injury. Acta Neurobiol. Exp. 2014;74:172&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">24993627</ArticleId></ArticleIdList></Reference><Reference><Citation>Slawinska U., Miazga K., Jordan L.M. 5-HT(2) and 5-HT(7) receptor agonists facilitate plantar stepping in chronic spinal rats through actions on different populations of spinal neurons. Front. Neural Circuits. 2014;8:95. doi: 10.3389/fncir.2014.00095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2014.00095</ArticleId><ArticleId IdType="pmc">PMC4137449</ArticleId><ArticleId IdType="pubmed">25191231</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray K.C., Nakae A., Stephens M.J., Rank M., D&#x2019;Amico J., Harvey P.J., Li X., Harris R.L., Ballou E.W., Anelli R., et al. Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors. Nat. Med. 2010;16:694&#x2013;700. doi: 10.1038/nm.2160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2160</ArticleId><ArticleId IdType="pmc">PMC3107820</ArticleId><ArticleId IdType="pubmed">20512126</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray K.C., Stephens M.J., Ballou E.W., Heckman C.J., Bennett D.J. Motoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity. J. Neurophysiol. 2011;105:731&#x2013;748. doi: 10.1152/jn.00774.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00774.2010</ArticleId><ArticleId IdType="pmc">PMC3059173</ArticleId><ArticleId IdType="pubmed">20980537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas-Osma A.M., Li Y., Murray K., Lin S., Black S., Stephens M.J., Ahn A.H., Heckman C.J., Fenrich K.K., Fouad K., et al. 5-HT1D receptors inhibit the monosynaptic stretch reflex by modulating C-fiber activity. J. Neurophysiol. 2019;121:1591&#x2013;1608. doi: 10.1152/jn.00805.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00805.2018</ArticleId><ArticleId IdType="pmc">PMC6589716</ArticleId><ArticleId IdType="pubmed">30625007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyer D., Hannon J.P., Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharm. Biochem. Behav. 2002;71:533&#x2013;554. doi: 10.1016/S0091-3057(01)00746-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0091-3057(01)00746-8</ArticleId><ArticleId IdType="pubmed">11888546</ArticleId></ArticleIdList></Reference><Reference><Citation>Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharm. Rev. 1992;44:401&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">1359584</ArticleId></ArticleIdList></Reference><Reference><Citation>Navailles S., De Deurwaerdere P. Presynaptic control of serotonin on striatal dopamine function. Psychopharmacol. (Berl.) 2011;213:213&#x2013;242. doi: 10.1007/s00213-010-2029-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-010-2029-y</ArticleId><ArticleId IdType="pubmed">20953589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandyk R. Serotonergic mechanisms in amyotrophic lateral sclerosis. Int. J. Neurosci. 2006;116:775&#x2013;826. doi: 10.1080/00207450600754087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207450600754087</ArticleId><ArticleId IdType="pubmed">16861147</ArticleId></ArticleIdList></Reference><Reference><Citation>Milan L., Barriere G., De Deurwaerdere P., Cazalets J.R., Bertrand S.S. Monoaminergic control of spinal locomotor networks in SOD1G93A newborn mice. Front. Neural Circuits. 2014;8:77. doi: 10.3389/fncir.2014.00077.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2014.00077</ArticleId><ArticleId IdType="pmc">PMC4081764</ArticleId><ArticleId IdType="pubmed">25071458</ArticleId></ArticleIdList></Reference><Reference><Citation>Dentel C., Palamiuc L., Henriques A., Lannes B., Spreux-Varoquaux O., Gutknecht L., Rene F., Echaniz-Laguna A., Gonzalez de Aguilar J.L., Lesch K.P., et al. Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: A link to spasticity. Brain. 2013;136:483&#x2013;493. doi: 10.1093/brain/aws274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws274</ArticleId><ArticleId IdType="pubmed">23114367</ArticleId></ArticleIdList></Reference><Reference><Citation>El Oussini H., Scekic-Zahirovic J., Vercruysse P., Marques C., Dirrig-Grosch S., Dieterle S., Picchiarelli G., Sinniger J., Rouaux C., Dupuis L. Degeneration of serotonin neurons triggers spasticity in amyotrophic lateral sclerosis. Ann. Neurol. 2017 doi: 10.1002/ana.25030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25030</ArticleId><ArticleId IdType="pubmed">28856708</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramu G., Pillez A., Leonardelli J. Serotonin axons of the ependyma and circumventricular organs in the forebrain of the guinea pig. An immunohistochemical study. Cell Tissue Res. 1983;228:297&#x2013;311. doi: 10.1007/BF00204880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00204880</ArticleId><ArticleId IdType="pubmed">6337717</ArticleId></ArticleIdList></Reference><Reference><Citation>Bormann J., Hamill O.P., Sakmann B. Mechanism of anion permeation through channels gated by glycine and gamma-aminobutyric acid in mouse cultured spinal neurones. J. Physiol. 1987;385:243&#x2013;286. doi: 10.1113/jphysiol.1987.sp016493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1987.sp016493</ArticleId><ArticleId IdType="pmc">PMC1192346</ArticleId><ArticleId IdType="pubmed">2443667</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao B.X., Ziskind-Conhaim L. Development of glycine- and GABA-gated currents in rat spinal motoneurons. J. Neurophysiol. 1995;74:113&#x2013;121. doi: 10.1152/jn.1995.74.1.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.1995.74.1.113</ArticleId><ArticleId IdType="pubmed">7472315</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitoussi A., Dellu-Hagedorn F., De Deurwaerdere P. Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition. Neuroscience. 2013;255:233&#x2013;245. doi: 10.1016/j.neuroscience.2013.09.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.09.059</ArticleId><ArticleId IdType="pubmed">24120557</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellu-Hagedorn F., Fitoussi A., De Deurwaerdere P. Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction. J. Neurosci. Methods. 2017;280:54&#x2013;63. doi: 10.1016/j.jneumeth.2017.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2017.01.020</ArticleId><ArticleId IdType="pubmed">28161298</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>